SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 |
_________________ |
FORM 8-K |
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
August 1, 2003 Date of Report (Date of Earliest Event Reported) |
GENELABS TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter) |
0-19222 | 94-3010150 |
(Commission File Number) | (IRS Employer Identification No.) |
505 Penobscot Drive Redwood City, California | 94063 |
(Address of Principal Executive Offices) | (Zip Code) |
(650) 369-9500 (Registrant's Telephone Number, including Area Code) |
Item 5. Other Events |
On August 1, 2003, Genelabs Technologies, Inc. (“Genelabs”) issued a press release announcing it had completed the sale of 1,666,667 shares of its common stock to one institutional investor (the “Purchaser”) at a price of $1.595 per share, for gross proceeds of $2,658,333. Genelabs also issued to the investor warrants to purchase of an additional 1,666,667 shares of Genelabs’ common stock at an exercise price of $1.50 per share in connection with the sale. |
Item 7. Exhibits |
EXHIBIT NO. | DESCRIPTION |
10.1 | Securities Purchase Agreement, by and between Genelabs and the Purchaser dated as of August 1, 2003. |
99.1 | Press Release dated August 1, 2003. |
SIGNATURE |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunder duly authorized. |
Dated: | August 1, 2003 | GENELABS TECHNOLOGIES, INC. |
By: | /s/ Heather Criss Keller | |||
Name: | Heather Criss Keller | |
Title: | Vice President, General Counsel |
EXHIBIT INDEX |
EXHIBIT NO. | DESCRIPTION |
10.1 | Securities Purchase Agreement, by and between Genelabs and the Purchaser dated as of August 1, 2003. |
99.1 | Press Release dated August 1, 2003. |